BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 2012085)

  • 21. Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes.
    Johansen A; Kanijo B; Fredheim S; Olsen B; Hertz B; Lauridsen MH; Andersen ML; Mortensen HB; Svensson J;
    Pediatr Diabetes; 2015 Aug; 16(5):354-60. PubMed ID: 25039921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycemia in the treated diabetic patient. A risk of intensive insulin therapy.
    Tamborlane WV; Amiel SA
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):313-27. PubMed ID: 1612068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).
    The Diabetes Control and Complications Trial Research Group
    Diabetologia; 1998 Apr; 41(4):416-23. PubMed ID: 9562345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hypoglycemia in children and adolescents with IDDM: frequency and associated factors.
    Limbert C; Schwingshandl J; Haas J; Roth R; Borkenstein M
    J Diabetes Complications; 1993; 7(4):216-20. PubMed ID: 8219364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    Diabetes; 1988 Apr; 37(4):476-81. PubMed ID: 2897940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial.
    Delahanty LM; Halford BN
    Diabetes Care; 1993 Nov; 16(11):1453-8. PubMed ID: 8299434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired stimulation of gluconeogenesis during prolonged hypoglycemia in intensively treated insulin-dependent diabetic subjects.
    Caprio S; Napoli R; Saccà L; Tamborlane WV; Sherwin RS
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1076-80. PubMed ID: 1400874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
    Schiel R; Ulbrich S; Müller UA
    Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Moss S
    Arch Intern Med; 1995 Apr; 155(7):745-54. PubMed ID: 7695463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
    Diabetes; 1986 May; 35(5):530-45. PubMed ID: 2869996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
    Murata GH; Duckworth WC; Shah JH; Wendel CS; Mohler MJ; Hoffman RM
    J Diabetes Complications; 2005; 19(1):10-7. PubMed ID: 15642485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counterregulatory mechanisms to insulin-induced hypoglycemia in humans: relevance to the problem of intensive treatment of IDDM.
    Bolli GB
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():103-15. PubMed ID: 9642648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe hypoglycemia in children with IDDM. A prospective population study, 1992-1994.
    Nordfeldt S; Ludvigsson J
    Diabetes Care; 1997 Apr; 20(4):497-503. PubMed ID: 9096968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM
    Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A risk-benefit assessment of conventional versus intensive insulin therapy.
    Reichard P
    Drug Saf; 1994 Mar; 10(3):196-202. PubMed ID: 8043222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Retrospective analysis of the incidence of severe hypoglycemia in 458 type 1 diabetic patients].
    Bali C; Gurdet C; Irsigler K
    Acta Med Austriaca; 1997; 24(5):165-9. PubMed ID: 9480616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM.
    Gonder-Frederick L; Cox D; Kovatchev B; Julian D; Clarke W
    Diabetes Care; 1997 Oct; 20(10):1543-6. PubMed ID: 9314632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problems of hypoglycemia arising in children and adolescents with insulin-dependent diabetes mellitus. The Diabetes Study Group of The Italian Society of Pediatric Endocrinology & Diabetes.
    Dammacco F; Torelli C; Frezza E; Piccinno E; Tansella F
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():167-76. PubMed ID: 9642656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients.
    Linn T; Ortac K; Laube H; Federlin K
    Metabolism; 1996 Dec; 45(12):1508-13. PubMed ID: 8969284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for frequent and severe hypoglycemia in type 1 diabetes.
    Allen C; LeCaire T; Palta M; Daniels K; Meredith M; D'Alessio DJ;
    Diabetes Care; 2001 Nov; 24(11):1878-81. PubMed ID: 11679450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.